Insight

Photo from The Institute of Cancer Research/LinkedIn

Sep 7, 2024, 15:31

Potential drug to target a rare childhood brain tumour – ICR

The Institute of Cancer Research (ICR) shared a post on LinkedIn:

“News: Research reveals a potential drug to target a rare childhood brain tumour.

ICR scientists and Dana-Farber Cancer Institute found a key weakness in the tumour cells which could be targeted by ribociclib, a drug already used to treat breast cancer.

Read more about the research, funded by The Brain Tumour Charity.”

Potential drug to target a rare childhood brain tumour - ICR

Source: The Institute of Cancer Research/LinkedIn

More posts featuring The Institute of Cancer Research on oncodaily.com

cancer childhood brain tumour Dana-Farber Cancer Institute ICR OncoDaily Oncology Ribociclib The Brain Tumour Charity The Institute of Cancer Research

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology